Stuart J. Mundell

University Walk
Bristol, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Synthesis, Modeling, and Biological Properties of Fluoroprostacyclin Analogues: Potent Agonists for Prostanoid Receptors.

Synthesis, Modeling, and Biological Properties of Fluoroprostacyclin Analogues: Potent Agonists for Prostanoid Receptors.

Journal: Journal of medicinal chemistry

Published: July 27, 2026

Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent.

Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 15, 2024

Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors.

Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors.

Journal: British journal of pharmacology

Published: October 10, 2023

Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19.

Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 12, 2022

Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate.

Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate.

Journal: British journal of pharmacology

Published: June 28, 2022

GPR56, a novel platelet collagen receptor that loves stress.

GPR56, a novel platelet collagen receptor that loves stress.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 24, 2021

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.

Journal: Journal of the American Heart Association

Published: December 11, 2020

Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling.

Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling.

Journal: Blood advances

Published: August 12, 2020

Arrestin-3 differentially regulates platelet GPCR subsets.

Arrestin-3 differentially regulates platelet GPCR subsets.

Journal: Platelets

Published: November 06, 2019

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Journal: Haematologica

Published: April 01, 2019

TBXA2R gene variants associated with bleeding.

TBXA2R gene variants associated with bleeding.

Journal: Platelets

Published: August 09, 2018

Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding.

Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 29, 2017

Showing 1-12 of 38

Last Updated: 09/26/2026